Liver cancer screening trial aims to cut deaths in cirrhosis patients

NCT ID NCT07469319

Recruiting now Prevention Sponsor: University of Aarhus Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether offering a liver ultrasound and blood test every 6 months to people with cirrhosis can catch liver cancer early and reduce deaths. About 617 adults aged 40-79 with compensated cirrhosis (no severe complications) in one region of Denmark will be offered screening. Their outcomes will be compared to similar patients in other Danish regions who do not receive regular screening.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cirrhosis of liver Fibrosis hepatocellular carcinoma prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CIRRHOSIS HEPATOCELLULAR CARCINOMA (HCC)

Contacts and locations

Locations

Aarhus University Hospital
RECRUITING

Aarhus, Central Jutland, 8200, Denmark
Horsens Regional Hospital
RECRUITING

Horsens, Central Jutland, 8700, Denmark
Randers Regional Hospital
RECRUITING

Randers, Central Jutland, 8930, Denmark
Regional Hospital Gødstrup
RECRUITING

Herning, Central Jutland, 7400, Denmark
Silkeborg Regional Hospital
RECRUITING

Silkeborg, Central Jutland, 8600, Denmark
Viborg Regional Hospital
RECRUITING

Viborg, Central Jutland, 8800, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.